Anti-Osteopontin antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | Osteopontin |
| Immunogen: | Peptide |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Immunohistochemistry (1:50-1:200); ELISA (1:5000-1:10000) |
| Reactivity: | Human, Mouse |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 0.5% BSA, 50% glycerol, 0.05% NaN3. |
| Concentration: | 1mg/ml |
| Purity: | Peptide affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | BNSP antibody |
| Bone sialoprotein 1 antibody | |
| BSP I antibody | |
| BSPI antibody | |
| Early T lymphocyte activation 1 antibody | |
| ETA 1 antibody | |
| ETA1 antibody | |
| MGC110940 antibody | |
| Nephropontin antibody | |
| OPN antibody | |
| Osteopontin antibody | |
| osteopontin/immunoglobulin alpha 1 heavy chain constant region fusion protein antibody | |
| OSTP_HUMAN antibody | |
| PSEC0156 antibody | |
| secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) antibody | |
| Secreted phosphoprotein 1 antibody | |
| SPP 1 antibody | |
| SPP-1 antibody | |
| SPP1 antibody | |
| SPP1/CALPHA2 fusion antibody |
Show More
Target information
Binds tightly to hydroxyapatite. Appears to form an integral part of the mineralized matrix. Probably important to cell-matrix interaction.
Acts as a cytokine involved in enhancing production of interferon-gamma and interleukin-12 and reducing production of interleukin-10 and is essential in the pathway that leads to type I immunity.
Provider
Erpantech Laboratory
